Anja Maria Weidner1, Henrik J. Michaely1, Andreas Lemke2, Lutz Breitinger3, Maurice S. Michel4, Frederik Wenz5, Natascha Schnitzer1, Stefan O. Schnberg1, Dietmar Jrg Dinter1
1Department of Clinical Radiology and Nuclear Medicine, University Medical Center, Mannheim, Germany; 2Computer Assisted Clinical Medicine, University Medical Center, Mannheim, Germany; 3 4Department of Urology, University Medical Center, Mannheim, Germany; 5Department of Radiation Oncology, University Medical Center, Mannheim, Germany
MRI of the prostate using T2, DWI, DCE and MRS allows in a combined approach to reliably detect and stage prostate cancer. Particularly fusion of T2 and DWI seems to be helpful for screening with a high negative predictive value.